(RTTNews) - Onex Corporation (ONEX.TO) reported fourth quarter net earnings of $181 million, or $2.64 per share, compared to a net loss of $2 million, or $0.02 per share, in the same period of 2024. Total segment net earnings per fully diluted share was $2.28 compared to $0.62.
(RTTNews) - Onex Corporation (ONEX.TO) reported fourth quarter net earnings of $181 million, or $2.64 per share, compared to a net loss of $2 million, or $0.02 per share, in the same period of 2024. Total segment net earnings per fully diluted share was $2.28 compared to $0.62.
Panama7/iStock Editorial via Getty Images Texas Attorney General Ken Paxton (R) has filed a lawsuit against Sanofi ( SNY ), accusing the French pharma giant of illegally running a kickback scheme aimed at encouraging doctors to prescribe its medicines. By providing healthcare providers with nurse services and insurance support services as part of its "Free Nurse Program” and “Support Services Prog...
Panama7/iStock Editorial via Getty Images Texas Attorney General Ken Paxton (R) has filed a lawsuit against Sanofi ( SNY ), accusing the French pharma giant of illegally running a kickback scheme aimed at encouraging doctors to prescribe its medicines. By providing healthcare providers with nurse services and insurance support services as part of its "Free Nurse Program” and “Support Services Program," the company influenced the kind of drugs Texans received, according to the lawsuit. With some of Sanofi’s ( SNY ) drugs used to treat chronic ailments, the scheme ensured that Sanofi ( SNY ) received years-long sources of revenue even though the drugs were not the most appropriate course of therapy for the patients. The kickbacks violated the Texas Health Care Program Fraud Prevention Act (“THFPA”), Paxton said in a statement, adding that he is seeking monetary relief of over $1M, including civil penalties, as well as an injunction to halt any further illegal acts. The lawsuit marked Paxton’s latest attempt to challenge Big Pharma. In August, he sued Eli Lilly ( LLY ) over allegations that the Indiana-based pharma giant bribed medical providers to boost prescriptions for its weight loss therapy Zepbound and other drugs. More on Sanofi Sanofi: CEO Leaves With Project Rejuvenation Unfinished, But Stock Undervalued Sanofi (SAN:CA) Q4 2025 Earnings Call Transcript Sanofi 2025 Q4 - Results - Earnings Call Presentation Sanofi replaces CEO Paul Hudson, names Belén Garijo as successor Regeneron posts Q4 beat as Sanofi collaboration offsets Eylea headwinds
Texas Roadhouse ( TXRH ) declares $0.75/share quarterly dividend . Forward yield 1.64% Payable March 31; for shareholders of record March 17; ex-div March 17. See TXRH Dividend Scorecard, Yield Chart, & Dividend Growth. More on Texas Roadhouse Texas Roadhouse, Inc. (TXRH) Q4 2025 Earnings Call Transcript Texas Roadhouse: Quietly Compounding While The Restaurant Industry Struggles Texas Roadhouse: ...
Texas Roadhouse ( TXRH ) declares $0.75/share quarterly dividend . Forward yield 1.64% Payable March 31; for shareholders of record March 17; ex-div March 17. See TXRH Dividend Scorecard, Yield Chart, & Dividend Growth. More on Texas Roadhouse Texas Roadhouse, Inc. (TXRH) Q4 2025 Earnings Call Transcript Texas Roadhouse: Quietly Compounding While The Restaurant Industry Struggles Texas Roadhouse: Attractively Valued, But Beef Prices Hurt (Rating Upgrade) Texas Roadhouse outlines 1.9% menu price increase and targets 35 new company-owned openings for 2026 amid sustained sales growth Texas Roadhouse sees higher commodity costs pull margins lower
Turkey has arrested six European activists who came to the country to examine prison conditions of political detainees, their lawyer said on Friday. They were detained in Istanbul on Thursday after meeting a legal collective called the Office of People’s Rights (HHB), said Naim Eminoglu, head of the Istanbul section of the Progressive Lawyers Association (CHD), who is defending them. The six were ...
Turkey has arrested six European activists who came to the country to examine prison conditions of political detainees, their lawyer said on Friday. They were detained in Istanbul on Thursday after meeting a legal collective called the Office of People’s Rights (HHB), said Naim Eminoglu, head of the Istanbul section of the Progressive Lawyers Association (CHD), who is defending them. The six were from Italy, France, Spain, Belgium and Russia, he said. Known for defending individuals seen as...
Barclays believes that even as the GLP-1 race heats up, Eli Lilly still has a leg up over competitors. The bank initiated the biopharmaceutical stock with an overweight rating and $1,350 price target, implying an upside 32% from here. Analyst Emily Field pointed to the growing business of obesity-treating GLP-1 drugs. "Unlike the prior go-to treatments for obesity (i.e. diet and exercise) we do no...
Barclays believes that even as the GLP-1 race heats up, Eli Lilly still has a leg up over competitors. The bank initiated the biopharmaceutical stock with an overweight rating and $1,350 price target, implying an upside 32% from here. Analyst Emily Field pointed to the growing business of obesity-treating GLP-1 drugs. "Unlike the prior go-to treatments for obesity (i.e. diet and exercise) we do not view the medical treatment of obesity as a fad, and believe GLP-1(+)s represent a durable structural shift, with Eli Lilly likely to remain the market leader," she wrote. LLY 1Y mountain LLY 1Y chart Field wrote that the obesity market is sure to see new competition enter the space, with potential rivals to Eli Lilly including AstraZeneca, Amgen and Roche. However, she believes that Eli Lilly's tirzepatide is "the best product available today, both from a safety and efficacy perspective and amongst competitors, as the market becomes segmented, LLY has likely near-best, if not best-in-class, options among emerging combinations and modalities." Going forward, Field expects investor focus to remain on the launch trajectory of Eli Lilly's orforglipron, a once-daily oral GLP-1 medication that is expected to be approved in the second quarter of 2026. She added that she's also bullish about the potential from injectables both with a higher efficacy potential that tirzepatide, combined with a milder toxicity profile. Field also applauded Eli Lilly's best-in-class consumer platform. "Another factor that we think will make it tough for a new entrant to put a dent into LLY's share in this space is the company's patient-centric focus and direct-to-consumer platform in Lilly Direct," she wrote. "Though we've now seen a major price reset following last year's announcements with both Novo and Lilly and the Trump Administration and Medicare coverage is likely to open up a new volume channel later this year, we expect this will be a market where consumers seek treatment increasingly direc...
Telephone and Data Systems press release ( TDS ): Q4 GAAP EPS of $0.32 beats by $0.23 . Revenue of $330.7M (+12.0% Y/Y) beats by $11.42M . TDS Telecom 2026 EstimatedResults Actual Results forthe Year EndedDecember 31, 2025* (Dollars in millions) Total operating revenues $1,015-$1,055 consensus is $1.28B $1,038 Adjusted OIBDA 1 (Non-GAAP) $300-$340 $319 Adjusted EBITDA 1 (Non-GAAP) $310-$350 $330 C...
Telephone and Data Systems press release ( TDS ): Q4 GAAP EPS of $0.32 beats by $0.23 . Revenue of $330.7M (+12.0% Y/Y) beats by $11.42M . TDS Telecom 2026 EstimatedResults Actual Results forthe Year EndedDecember 31, 2025* (Dollars in millions) Total operating revenues $1,015-$1,055 consensus is $1.28B $1,038 Adjusted OIBDA 1 (Non-GAAP) $300-$340 $319 Adjusted EBITDA 1 (Non-GAAP) $310-$350 $330 Capital expenditures $550-$600 $406 * The 2025 divestitures at TDS Telecom impact year-over-year comparisons. The divested markets contributed $19M in annual revenues in 2025. Array 2026 EstimatedResults Actual Results forthe Year EndedDecember 31, 2025 (Dollars in millions) Total operating revenues $200-$215 $163 Adjusted OIBDA 1 (Non-GAAP) $50-$65 $1 Adjusted EBITDA 1 (Non-GAAP) $200-$215 $194 Capital expenditures $25-$35 $30 Click to enlarge More on Telephone and Data Systems The New Telephone and Data Systems Telephone and Data Systems: Pending Spectrum Sales Set To Drive Further Deleveraging Telephone And Data Systems Preferreds Offer Highest Investment Grade Yield Telephone and Data Systems Q4 Earnings Preview Seeking Alpha’s Quant Rating on Telephone and Data Systems
F&G Annuities & Life ( FG ) declares $0.25/share quarterly dividend , in line with previous. Forward yield 3.61% Payable March 31; for shareholders of record March 17; ex-div March 17. See FG Dividend Scorecard, Yield Chart, & Dividend Growth. More on F&G Annuities & Life F&G Annuities & Life: Technical Pressure Creates A Compelling Value Opportunity Seeking Alpha’s Quant Rating on F&G Annuities &...
F&G Annuities & Life ( FG ) declares $0.25/share quarterly dividend , in line with previous. Forward yield 3.61% Payable March 31; for shareholders of record March 17; ex-div March 17. See FG Dividend Scorecard, Yield Chart, & Dividend Growth. More on F&G Annuities & Life F&G Annuities & Life: Technical Pressure Creates A Compelling Value Opportunity Seeking Alpha’s Quant Rating on F&G Annuities & Life Historical earnings data for F&G Annuities & Life Dividend scorecard for F&G Annuities & Life Financial information for F&G Annuities & Life
Fidelity National Financial ( FNF ) declares $0.52/share quarterly dividend , in line with previous. Forward yield 3.84% Payable March 31; for shareholders of record March 17; ex-div March 17. See FNF Dividend Scorecard, Yield Chart, & Dividend Growth. More on Fidelity National Financial Fidelity National Financial: A Classic Case Of Outdated Market Fears Fidelity National Financial, Inc. (FNF) Pr...
Fidelity National Financial ( FNF ) declares $0.52/share quarterly dividend , in line with previous. Forward yield 3.84% Payable March 31; for shareholders of record March 17; ex-div March 17. See FNF Dividend Scorecard, Yield Chart, & Dividend Growth. More on Fidelity National Financial Fidelity National Financial: A Classic Case Of Outdated Market Fears Fidelity National Financial, Inc. (FNF) Presents at KBW Title Insurance Day Transcript Fidelity National Financial Non-GAAP EPS of $1.41 misses by $0.09, revenue of $4.05B beats by $390M Fidelity National Financial Q4 2025 Earnings Preview Seeking Alpha’s Quant Rating on Fidelity National Financial
Welcome to Next Africa, a twice-weekly newsletter on where the continent stands now — and where it’s headed. Sign up here to have it delivered to your email. A little over three years ago, Ethiopia’s government and the leadership of the northern Tigray region agreed to end a civil war that killed hundreds of thousands of people and displaced millions more. Missing from that pact, though, was Eritr...
Welcome to Next Africa, a twice-weekly newsletter on where the continent stands now — and where it’s headed. Sign up here to have it delivered to your email. A little over three years ago, Ethiopia’s government and the leadership of the northern Tigray region agreed to end a civil war that killed hundreds of thousands of people and displaced millions more. Missing from that pact, though, was Eritrea — the secretive, militarized nation to the east that fought for decades over independence from Ethiopia before siding with new President Abiy Ahmed against the Tigrayans. The tables have turned again. This time Eritrea is on the same side as Tigray following months of rising tensions with Addis Ababa. The governments are deploying troops and military equipment to their border, according to regional diplomats. The animosity is historical, but has been fueled of late by rhetoric from Abiy over his nation’s lack of access to the ocean — lost through Eritrea’s secession three decades ago. “Due to our enemies’ plot, keeping Ethiopia a geographic prisoner for so long is not right,” Abiy said at a joint briefing with visiting Turkish President Recep Tayyip Erdoğan this week. “Logistics is the major bottleneck to our growth, and sea access is the key.” Many suspect Abiy now has eyes on taking Eritrea back. It’s a region already crippled by fighting. Tigray is still struggling to rebuild, while in neighboring Sudan, a three-year conflict between the army and a paramilitary force has exacted what the United Nations terms the world’s worst humanitarian crisis. To the south, jihadists have been waging war against the Somali government for years. A broader power play raises the risk of wider conflict. The United Arab Emirates has backed Abiy with financial aid in recent years, while Egypt and Saudi Arabia positioned themselves as close allies of Eritrea and the Tigrayans. Sudan and Egypt are already angered by Ethiopia’s giant new dam that blocks the flow of the Nile. Once again, the...
Telephone and Data Systems ( TDS ) declares $0.04/share quarterly dividend , in line with previous. Forward yield 0.35% Payable March 31; for shareholders of record March 16; ex-div March 16. See TDS Dividend Scorecard, Yield Chart, & Dividend Growth. More on Telephone and Data Systems The New Telephone and Data Systems Telephone and Data Systems: Pending Spectrum Sales Set To Drive Further Deleve...
Telephone and Data Systems ( TDS ) declares $0.04/share quarterly dividend , in line with previous. Forward yield 0.35% Payable March 31; for shareholders of record March 16; ex-div March 16. See TDS Dividend Scorecard, Yield Chart, & Dividend Growth. More on Telephone and Data Systems The New Telephone and Data Systems Telephone and Data Systems: Pending Spectrum Sales Set To Drive Further Deleveraging Telephone And Data Systems Preferreds Offer Highest Investment Grade Yield Telephone and Data Systems Q4 Earnings Preview Seeking Alpha’s Quant Rating on Telephone and Data Systems